Clinical TrialsSearch results
Number of results: 407
Recruiting
- Efficacy of butyric acid preparations in patients with hepatocellular carcinoma undergoing chemotherapy
- Unresectable hepatocellular carcinoma
- Otsuka Motoyuki
- 2023-11-15
Recruiting
- Study of HAIC added on chemotherapy in patients with with unresectable advanced Hepatocellular Carcinoma
- Unresectable advanced Hepatocellular Carcinoma
- Takeuchi Yasuto
- 2021-12-17
Other
- Prospective randomized controlled study for the therapeutic effect of removing uremic toxins on endothelial function in undialyzed patients with chronic renal failure
- Undialyzed patients with chronic renal failure
- Division of Nephrology, Department of Internal Medicine, Kawasaki Medical School
- 2008-10-01
Other
- Establishment of surveillance system for the longstanding ulcerative colitis patients Comparative study of efficacy for the targeted biopsy and the step biopsy
- Ulcerative colitis
- Teikyo University School of Medicine
- 2009-01-05
Other
- Reversal of diabetes and prevention of arteriosclerosis in type 2 diabetic patients with oral antidiabetic agents
- Type2 Diabetes Mellitus
- PREVENT-J Study Steering Committee
- 2007-12-14
Completed
- Effect of Semaglutide 2.4 mg once-weekly on function and symptoms in subjects with obesity-related heart failure with preserved ejection fraction, and type 2 diabetes
- Type2 diabetes and obesity-related heart failure with preserved ejection fraction
- Kinoshita Kazunori
- 2021-06-17
Other
- Clinical study of combinational therapy of AD-4833 with metformin -Phase III double-blind comparative study-
- Type2 Diabetes
- Takeda Pharmaceutical Company Limited
- 2008-04-04
Other
- Effect of canagliflozin in type 2 diabetic patients with microalbuminuria in Japanese population
- Type 2 diabetes with microalbuminuria
- Miyamoto Satoshi
- 2019-03-12
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Thiazolidine
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2008-10-01
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09